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Abstract
Background: Swine is an important agricultural commodity and biomedical model. Manipulation
of the pig genome provides opportunity to improve production efficiency, enhance disease
resistance, and add value to swine products. Genetic engineering can also expand the utility of pigs
for modeling human disease, developing clinical treatment methodologies, or donating tissues for
xenotransplantation. Realizing the full potential of pig genetic engineering requires translation of the
complete repertoire of genetic tools currently employed in smaller model organisms to practical
use in pigs.
Results: Application of transposon and recombinase technologies for manipulation of the swine
genome requires characterization of their activity in pig cells. We tested four transposon systems-
Sleeping Beauty, Tol2, piggyBac, and Passport in cultured porcine cells. Transposons increased the
efficiency of DNA integration up to 28-fold above background and provided for precise delivery of
1 to 15 transgenes per cell. Both Cre and Flp recombinase were functional in pig cells as measured
by their ability to remove a positive-negative selection cassette from 16 independent clones and
over 20 independent genomic locations. We also demonstrated a Cre-dependent genetic switch
capable of eliminating an intervening positive-negative selection cassette and activating GFP
expression from episomal and genome-resident transposons.
Conclusion: We have demonstrated for the first time that transposons and recombinases are
capable of mobilizing DNA into and out of the porcine genome in a precise and efficient manner.
This study provides the basis for developing transposon and recombinase based tools for genetic
engineering of the swine genome.
Background
Recent developments in livestock transgenesis, including
somatic cell nuclear transfer (SCNT, cloning) [1], and
stem cell biology [2,3] have energized plans to engineer
the pig genome for both agricultural and emerging bio-
medical markets. Although pronuclear injection (PNI)
and SCNT are proven methods for gene supplementation
and gene targeting, respectively, more sophisticated meth-
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ods for manipulating the pig genome have been lacking.
Tandem gene targeting and SCNT provides a method for
the precise introduction of transgenes or alternate alleles,
but the inherent inefficiency of homologous recombina-
tion and donor-cell senescence limits its efficiency. Trans-
genesis by random integration of naked DNA has proven
much more efficient for gene supplementation, whether
using PNI or SCNT. However, random integration of
naked DNA is often accompanied by transgene instability
[4,5], transgene concatemerization [6,7], loss of transgene
expression due to methylation [8-13], and short dele-
tions, inversions and duplications at the site of transgene
integration [14-25]. In addition, the lack of precision
associated with random integration of naked DNA limits
transgene manipulation and control post-integration.
DNA "cut and paste" transposons have been widely used
for precise and efficient delivery of DNA expression cas-
settes into invertebrate and plant genomes. Over the past
ten years, several DNA cut and paste transposon systems
have been shown to function in vertebrate cells, including
Sleeping Beauty (SB) [26,27], Passport (PP) [28,29], Tol2
[30,31], and piggyBac  (PB) [32-34]. In addition, trans-
posons have been used for germline transgenesis of fish
[35-37], frogs [38-40], and mice [32,41-43] and for trans-
genesis of mouse somatic and embryonic stem cells [44-
46]. It is noteworthy that although transposons function
in a wide array of cell types, their efficiency can differ from
species to species or even within various cell types of one
species. The function and efficacy of vertebrate trans-
posons in pig cells had not previously been examined.
Demonstration that one or more transposon systems
functions efficiently in porcine cells would provide a
rationale for investigating their use in PNI and SCNT. In
addition, the precision of transpositional transgenesis
(TnT) provides a segue to the development of conditional
expression systems for application in pigs and porcine
cells.
Many genes have roles in multiple tissues and/or at mul-
tiple times during growth and development. Due to a
requirement for strict regulation, global ectopic transgene-
expression or gene-knockout will be an implausible
approach for many targets. To overcome these limitations,
binary systems based on transcriptional transactivation or
DNA recombination have been developed and applied in
model organisms for conditional gene-expression or
silencing [47]. Although the tetracycline transcriptional
activator system [48] has been demonstrated to function
in transgenic pigs [49,50], recombinases have not. Cre
and Flp recombinases catalyze a conservative DNA recom-
bination event between two short recombinase recogni-
tion sites (RRS), loxP  and  FRT, respectively [51]. This
results in the deletion or inversion of the DNA between
two RRS- depending on their orientation. Deletion or
inversion of sequences in transgenes can be used as
genetic switches to activate or silence gene expression in
specific cells, at particular times, or under prescribed con-
ditions. Applications beyond conditional gene expression
include the removal/recycling of selectable markers or
transgenes [52] or chromosome engineering [53]. The
successful application of recombinase technologies to
porcine genetics requires the demonstration of Cre and/or
Flp activity in porcine cells and the efficient delivery of
RRS sites and recombinase-based expression vectors to the
porcine genome.
In order to assess the utility of DNA transposons and
recombinases for enzymatic engineering of the porcine
genome, we tested four transposon systems and two
recombinases. The SB, PP, Tol2, and PB transposon sys-
tems were able to function in cells derived from pig tissues
and significantly improved the rate of transgenesis in vitro.
Cre and Flp recombinases were capable of removing anti-
biotic selection cassettes in porcine cells and condition-
ally activating transgenes in porcine cells, demonstrating
the potential for their applications to "leave no trace"
and/or conditional porcine genetic engineering.
Results
Sleeping Beauty activity in porcine cells
To test the ability of the SB transposon systems to mediate
transposition into the porcine genome, a transposon vec-
tor (pT2-FloxP-PTK) and a transposase expression vector
(pKUb-SB11) were constructed (Fig 1A). The transposon
vector encodes a puromycin-thymidine kinase (PuroΔTK,
PTK) fusion protein [54] between the inverted repeats of
the SB transposon system. The PTK cassette was flanked by
both FRT and loxP sites so that it could be used as a sub-
strate for testing both Cre and Flp recombinases (see
below). Pig fetal fibroblasts (PFF) or porcine endometrial
gland epithelium (PEGE) cells were transfected with the
PTK transposon along with the SB expression vector, a vec-
tor encoding non-functional SB (pKUb-SBΔDDE), or a β-
galactosidase expression vector (pCMV-β). After the trans-
fection period, cells with integrations were rendered
resistant to puromycin selection, and formed clonal cell
colonies after 9–12 days. Clones were stained with meth-
ylene blue and quantified (Fig. 1B). The transposase cata-
lyzed 2.5× (PFF) -10× (PEGE) more colony formation
versus transfection with a non-functional transposase
(ΔDDE) or β-galactosidase. This difference in the rate of
clone formation corresponds to TnT versus the back-
ground rate of non-transpositional transgenesis.
Multiple transposon systems function in porcine cells
The success of the SB transposon system prompted inves-
tigation of three additional transposon systems. In addi-
tion to retesting the SB transposon system in PEGE cells,
we also tested PP (an additional member of the Tc1 trans-BMC Biotechnology 2007, 7:42 http://www.biomedcentral.com/1472-6750/7/42
Page 3 of 17
(page number not for citation purposes)
Sleeping Beauty function in pig cells Figure 1
Sleeping Beauty function in pig cells. A) Diagrams of the DNA vectors transfected into pig cells. pT2-FloxP-PTK is the 
experimental SB transposon. The transposon is flanked by inverted terminal repeats (ITR). The puromycin phosphotrans-
ferase-thymidine kinase fusion protein (PTK) is flanked by recombinase recognition sites, FRT and loxP, for Flp and Cre, respec-
tively. pKUb-SB11 is the source of transposase and is expressed from the ubiquitin promoter (Ub). pKUb-SBΔDDE is a non-
functional version of transposase because of an internal deletion within the catalytic domain. pCMV-β functions as negative 
control. B) The colony forming ability of pT2-FloxP-PTK in pig fetal fibroblast (PFF) and porcine endometrial gland epithelium 
(PEGE) was determined by counting puromycin resistant colonies after plating 60,000 cells on 10 cm dishes when pT2-FloxP-
PTK was co-transfected with pKUb-SB11 (+SB), pKUb-SBΔDDE (+SBΔDDE), or pCMV-β (+βgal). The addition of functional 
transposase (+SB) versus a non-functional transposase (SBΔDDE) or pCMV-β (Bgal) was determined to be significant by analy-
sis with an unpaired t-test (p-values < 0.000002).BMC Biotechnology 2007, 7:42 http://www.biomedcentral.com/1472-6750/7/42
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poson family [55]), Tol2 (a member of the hAT transpo-
son family [56]), and PB, the founding member of the
piggyBac transposon family [57]). PEGE cells are one of a
few immortalized pig cell lines available, transfect consist-
ently (8–15%), and form tight non-migrating clonal colo-
nies- essential characteristics for the colony forming
assays performed. The PTK expression cassette was placed
between inverted repeats corresponding to each transpo-
son; pKT2P-PTK, pPTnP-PTK, pGTol2P-PTK, and pPBT-
PTK, respectively (Fig. 2A). PEGE cells were co-transfected
with each of these transposons along with their corre-
sponding transposase expression construct; pKUb-SB11,
pKC-PTs1, pCMV-Tol2, or pKC-PB, respectively. Each
transposon vector was also co-transfected with pCMV-β to
determine the background rate of non-transpositional
integration. Transfected PEGE cells were placed under
puromycin selection for 9–12 days, colonies fixed,
stained, and enumerated. Again, transfection of PEGE
cells with both components of the SB system (Fig. 2B)
resulted in over 200 colonies per 60,000 plated cells, or
about 3.3% of transfected cells based on an average 10%
transfection efficiency. This represented a 13.5-fold
increase over transfection without transposase. Similar
enhancements to transgenesis were seen for all the trans-
poson systems. PP produced an average of over 100 colo-
nies per 60,000 cells; a 5-fold increase over transfection
without transposase (Fig 2C). The inclusion of Tol2 trans-
posase resulted in the generation of puromycin resistant
colonies at a rate 21-fold over transfections without trans-
posase (Fig. 2D), producing on average over 240 colonies
per 60,000 cells. The PB transposon system (Fig. 2E)
yielded an average of over 320 colonies per 60,000 cells
(about 5% of transfected cells), representing a 28-fold
increase over transfection without transposase.
Molecular characterization of transposition
Integration of DNA transposons produces target-site
duplications upon integration into the genome. Analo-
gous to SB and other Tc1 type transposons, the target site
preference for PP is a TA dinucleotide. Target-site prefer-
ence for the PB transposon is a TTAA tetranucleotide [33].
Integration of Tol2 results in a target-site duplication of
eight bases but does not rely on specific primary sequence,
instead targeting a characteristic local deformation of
DNA [58]. Blocked linker-mediated PCR was used to
clone junction fragments after transfection of PEGE cells
with each transposon system. Characteristic integration
footprints were observed for each transposon system (Fig
3). Junction sequences were compared to sequences in
GenBank using BLAST [59]. Despite the small amount of
contemporaneous porcine genome sequence available,
some flanking DNAs of each transposon system were
found to have high identity to the pig genome, in most
cases in abundant repetitive elements. This demonstrates
bona fide transposition into the porcine genome for each
transposon class.
One characteristic advantage of transposase-mediated
integration is the precise incorporation of one or more
independently transposed gene expression cassettes, with-
out adjacent plasmid vector. In order to observe represent-
ative integration events, DNA was isolated from 8 or 9
selected clones from each transposon and analyzed by
Southern hybridization (Fig 4). Non-transposase medi-
ated integrations, often head to tail concatemer repeats,
have a predictable hybridizing fragment size following
restriction enzyme digestion. However, transposon medi-
ated events have unique DNA outside of the ITRs and
therefore have unpredictable and varying fragment
lengths. The enhancement of transgenesis by transposi-
tion (as detected by increased colony formation) was sub-
stantiated by the presence of inserts of varying size in
cellular clones, in most cases without concatemers. The
level of TnT can also be measured by counting the number
of independent integrations per cellular clone. The more
active transposons Tol2 and PB, display multiple (up to
15) independent integration events. The wild-type PP
transposon system mediated a single integration event per
cellular clone, reflecting its lower activity in PEGE cells,
whereas the engineered SB system displayed an intermedi-
ate number of insertions.
CRE/FLP activity in porcine cells
To test the ability of Cre and/or Flp recombinase to func-
tion in porcine cells pT2-FloxP-PTK (Fig. 1A) was trans-
fected into PEGE cells along with SB. These clones were
obtained from preliminary transfections that were
selected under very stringent drug conditions that favored
high-copy integrations, particularly non-transposition
events. DNA from puromycin resistant clones was isolated
and analyzed by Southern hybridization. Isolated clones
contained multiple copies of the PTK transgene due to
non-transpositional integration, as indicated by concate-
mers and concatemer junction bands (Fig 5). PTK trans-
genic clones were subsequently transfected with pPGK-
nlsCre, pKT2P-nlsFlp, or pKT2C-EGFP. Excision of the
PTK cassette was detectable in transiently transfected cells
by PCR, and the sequence of the excision product con-
firmed by sequencing (data not shown). Transfected cells
were placed under selection with gancyclovir for 10–14
days and colonies counted (Fig. 5C). Only cells that had
excised the PTK gene could withstand gancyclovir selec-
tion. As expected for concatemers, we observed a low level
of transgene instability as evidenced by the appearance of
gancyclovir resistant clones upon transfection with
pKT2C-EGFP. A much more pronounced recombinase
stimulated elimination of the PTK cassette was demon-
strated by elevated resistant colony formation for 7 out of
8 of the clones transfected with either pPGK-nlsCre orBMC Biotechnology 2007, 7:42 http://www.biomedcentral.com/1472-6750/7/42
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pKT2P-nlsFlp. While Cre and Flp are both active in PEGE
cells, in all cases Cre mediated recombination/excision
matched or exceeded that observed for Flp. A single clone
(#6) never showed evidence of PTK elimination. The
Southern analysis (Fig. 5B), revealed a fragment of pT2-
FloxP-PTK likely resulting from the integration of a short-
ened PTK expression cassette lacking at least one flanking
RRS. This clipped PTK transgene is therefore unable to be
removed by recombinase-mediated excision.
CRE-activated gene expression
To further demonstrate the functionality of the transpo-
son based Cre recombinase system for use in porcine
genome engineering, a SB transposon containing a Cre-
activated gene expression cassette was constructed- pTC-
loxPTK-G (Fig. 6A). The PTK gene would be transcribed by
the mini-CAGs promoter and efficiently terminated by
three complete poly(A) signals (triple stop) in the intact
pTC-loxPTK-G [60]. Cre recombination results in deletion
Activity of multiple transposon systems in PEGE cells Figure 2
Activity of multiple transposon systems in PEGE cells. A) A drawing of a generic transposon (pTP-PTK) used for col-
ony formation assays. The transposons used, except the transposon-specific inverted terminal repeats, are identical. The vec-
tor backbones of the transposons are also identical except for pGTol2P-PTK. The pKx-Ts drawing is a generic representation 
of the transposase-expressing vector. The promoter choices include Ub, CMV, and mCAGs for SB, Tol2, and PB and PP, 
respectively. The vector backbones and poly(A) signals are identical except for pCMV-Tol2 B-E) The number of colonies 
formed with SB, PP, Tol2, or PB PTK transposons are shown with βgal instead of transposase (-Ts) and with transposase (+Ts), 
where Ts is SB, PP, Tol2, or PB. In each case, the significance of transposase was verified with an unpaired t-test (p-values ≤ 
0.00002).BMC Biotechnology 2007, 7:42 http://www.biomedcentral.com/1472-6750/7/42
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Examples of transposon insertion junctions Figure 3
Examples of transposon insertion junctions. Transposon junctions amplified from PEGE cells are shown in groups of five 
with expected non-transposed vector sequence (lowercase) highlighted above. From top to bottom, SB (ITR-L), PP (ITR-R), 
Tol2 (ITR-L), and PB (ITR-R), and. Target site duplications (bold) for each transposon are separated from genomic DNA and 
corresponding (ITR) by a space.BMC Biotechnology 2007, 7:42 http://www.biomedcentral.com/1472-6750/7/42
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Southern Blot of PEGE Clones Figure 4
Southern Blot of PEGE Clones. Individual puromycin resistant PEGE colonies were isolated and expanded for Southern 
analysis A) SB B) PP C) Tol2, and D) PB. Each transposon donor plasmid transfected into PEGE cells is diagramed with restric-
tion endonuclease sites used for DNA digestion and the probe fragment indicated (diagonal lined rectangle). Expected concate-
mer sizes (vertical lined arrow)/smallest possible transposition event (open arrow) for each transposon are 5159/3335 bp, 
5083/3275 bp, 6285/3346 bp, and 5140/3320 bp, respectively. The positions of the marker bands are indicated by black dots on 
the right of each blot with sizes of 12, 10, 8, 6, 5, 4, and 3 kb are shown.BMC Biotechnology 2007, 7:42 http://www.biomedcentral.com/1472-6750/7/42
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of the PTK/triple-stop cassette, thereby juxtaposing the
mini-CAGS promoter and the downstream gene expres-
sion cassette and enabling transcription of the GFP gene.
Conditional activation of GFP expression was assessed by
microscopy and flow cytometry after transient transfec-
tion of PEGE cells with pTC-loxPTK-G in the presence or
absence of pPGK-nlsCRE (Fig. 6B). There was no GFP
observed in cells transfected with pTC-loxPTK-G alone,
whereas about 10–12% of the cells were GFP+ when
transfected with pPGK-nlsCre. This corresponds well with
the average transfection efficiency of PEGE cells, indicat-
ing that the Cre excision reaction is very efficient in tran-
siently transfected cells.
To further examine the efficiency of Cre recombinase in
transiently transfected cells, conditional removal of the
PTK/triple stop expression cassette was assessed by selec-
tion in puromycin following co-transfection of PEGE cells
with pTC-loxPTK-G and either Cre, β-galactosidase, SB, or
Cre + SB. Transfected cells were plated under puromycin
selection for 9–12 days, stained with methylene blue, and
enumerated to quantify the efficiency of PTK/triple stop
elimination prior to or after integration into the genome
(Fig. 6C). Addition of pPGK-nlsCRE to the transfection,
alone or in combination with pKUb-SB11 reduced puro-
mycin-resistant colony counts to levels significantly lower
than that observed for pKUb-SB11 or pCMV-β, which
alone result in TnT and non-transpositional transgenesis
with an intact PTK gene expression cassette, respectively.
Therefore, Cre recombinase excision activity in transiently
transfected PEGE cells approaches 100%, especially with
regard to plasmids available for transposition by SB trans-
posase.
Although this particular co-transfection with pTC-loxPTK-
G and SB suffered from a low transfection efficiency
(~5%) that reduced TnT (compare Fig 6C to 1B), puromy-
cin resistant clones were expanded for characterization by
Southern hybridization (Fig 7). Analysis indicated TnT
with 1 to 4 transposon integrations per clone. Although,
Cre/Flp Activity in Pig Cells Figure 5
Cre/Flp Activity in Pig Cells. Individual puromycin resistant PEGE colonies were isolated and expanded for analysis. A) A 
diagram of the pT2-FloxP-PTK vector showing the location of restriction enzyme sites for SspI and the location of the PTK 
probe (diagonal lined rectangle). B) Southern analysis shows the number and size of vector inserts in several PEGE clones. The 
expected concatemer size of 5.6 kb (vertical lined arrow) as well as the smallest possible transposition event (open arrow) of 
3.3 kb are indicated on the left of the image. An asterisk is placed to the right of a band slightly smaller than 2 kb in lane 2 
(Clone #6). C) The rate of gancyclovir resistant colony formation after transfection of PEGE clones with pPGK-nlsCre (CRE), 
pKT2-nlsFlp (FLP), or pKT2C-EGFP (GFP). Values that are significantly different from the background (GFP) as determined by 
an unpaired t-test (p = 0.05) are designated with an asterik (*).BMC Biotechnology 2007, 7:42 http://www.biomedcentral.com/1472-6750/7/42
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A CRE-Activated Transgene Figure 6
A CRE-Activated Transgene. A) An illustration of the Cre-activated transgene vector. The full vector, pTC-loxPTK-G, 
produces PTK from the mini-CAGs promoter. Transcriptional leakage into the downstream gene, GFP, is limited due to the 
incorporation of three full poly-adenylation signals, a so-called triple-stop. Recombination by Cre eliminates PTK and triple-
stop, activating GFP expression from pTC-lox-G. B) pTC-loxPTK-G was transfected into PEGE cells with (+Cre) or without (-
Cre) pPGK-nlsCre. Cells were monitored for GFP expression by fluorescent microscopy (image inserts) and flow cytometry. 
The percentage of cells expressing GFP was dependent on co-transfection with pPGK-nlsCre. C) PEGE cells were transfected 
with pTC-loxPTK-G along with pPGK-nlsCre (+Cre), pCMV-β (+βgal), pKUb-SB11 (+SB), or pKUb-SB11 and pPGK-nlsCre 
(+SB +Cre). The cells were plated in puromycin selective media and colonies were counted.BMC Biotechnology 2007, 7:42 http://www.biomedcentral.com/1472-6750/7/42
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clones 7, 10 and perhaps 11 contained hybridizing species
near what would be expected for non-transpositional inte-
gration, their molar representation was equal to that of
single copy inserts, not multicopy concatemers. Clones 7
and 10 also harbored hybridizing species smaller than
was expected for transposition. These fragments likely rep-
resent non-transposase mediated DNA recombination
events. The proportion of non-transpositional integra-
tions detected by Southern analysis (1 in 4) corresponds
well with the observed unfacilitated rate of transgenesis as
determined by colony count for this transfection.
pTC-loxPTK-G clones were generated to analyze the effi-
ciency of recombinase-directed selection-cassette recy-
cling and the conditional activation of gene expression
from a variety of porcine genomic loci. Puromycin resist-
ant clones were transfected with pPGK-nlsCRE and scored
for gancylovir resistance (Fig 7C). All gancylovir resistant
clones expressed GFP, although variation in the intensity
of GFP was observed (data not shown) depending on the
parental clone source. This expression variance is expected
due to the influence of porcine sequence adjacent to the
sites of transposon integration, a phenomenon com-
monly referred to as "position effect". A significant
increase in the efficiency of selection cassette recycling was
demonstrated in the presence of single copy inserts when
compared to multicopy concatemers (Fig 7C vs 5C). In
addition, activation of GFP expression upon recombi-
nase-based excision from integrated transposons demon-
strates the efficacy of Cre-dependent conditional gene
expression in transgenic porcine cells.
Discussion
Multiple transposons and recombinases are active in 
porcine cells
This work demonstrates for the first time the capability of
four DNA transposon systems, SB, Tol2, PB, and PP, to
enzymatically facilitate precise and efficient transposi-
tional transgenesis in porcine cells. We have also estab-
lished for the first time that Cre and Flp DNA
recombinases are active in porcine cells. The combination
of these DNA directed enzyme systems provides for the
delivery and removal of gene expression cassettes to the
porcine genome for the purpose of cellular transgenesis,
selection cassette recycling and conditional gene expres-
sion based on transposons and recombinases. In these
studies, the Tol2 and PB transposon systems were more
efficient than SB, which was more efficient than PP at
mediating TnT in PEGE cells, although these relative effi-
ciencies should not be over-interpreted. Although we used
favorable conditions for each transposon system by our
selection of promoters and transposase/transposon ratios,
our focus here was on testing their function, not on deter-
mining their relative activities in PEGE cells, an immortal-
ized cell line unsuitable for generating pigs by SCNT.
Indeed, it is well established that the rate of TnT in any cell
type is likely to depend not only on intrinsic transposase
activity, but also on the presence or absence of cellular co-
factors and DNA repair enzymes, the method of DNA
introduction, and the amount of transposase produced/
provided in the specific cell type. Transposon activity var-
ies not only between cells from different species, but also
between different cell types from the same species
[26,27,34]. Future studies will focus on the efficiency of
different transposon systems and recombinases in pig
fibroblasts (applicable to SCNT), pig stem cells (for func-
tional genomics and SCNT), and porcine embryos (for
direct transgenesis by PNI).
In addition to potential differences in efficiency, the inte-
gration behavior of each transposon may be an important
factor in determining the appropriate transposon system
for a specific task. For instance, PB appears to preferen-
tially integrate into transcription units [32,61]. Consistent
with this observation, in our limited examination of inte-
gration sites in the pig genome, flanking sequence from
two of seven PB insertions matched porcine cDNAs. In
addition, PB primarily leaves no footprint when remobi-
lized [33]. Therefore, PB may be most suitable for func-
tional genomics studies in pigs or pig cells, where
mutations due to the interruption of genes, and the poten-
tial for precise transposition-based rescue is desirable [62-
65]. SB does not integrate into transcription units at a rate
much higher than what would be expected by random
integration [66], so it may represent a better choice for
animal transgenesis, transposon-based DNA vaccination,
or other somatic therapies. Alternatively transposon sys-
tems engineered to target specific genomic locations may
be developed and could provide the safest choice for these
applications [34,67,68]. The integration profiles of Tol2
and PP are not well characterized in any organism or cell
type, and the integration predilections of any transposon
system remains to be addressed in specific swine cells
being considered for engineering.
Advantages of transposition for pig transgenesis and 
genetics
There are several advantages of transpositional versus
unguided transgenesis. First, the enzymatic activity of the
transposase increases the efficiency of transgene integra-
tion (Fig. 1 and 2). Secondly, transposase-mediated trans-
genesis precisely integrates a single copy of the transposon
into one or more locations in the genome. Consequently,
transposition avoids the integration of G/C-rich prokary-
otic elements of the vector and avoids transgene concate-
merization, both of which can lead to shutdown of gene
expression [5,6]. In addition, concatemerization is prob-
lematic for selection cassette recycling (Fig. 5) and the
implementation of more complex genetic rearrangements
with recombinases. We propose the use of transposon sys-BMC Biotechnology 2007, 7:42 http://www.biomedcentral.com/1472-6750/7/42
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Conditional gene-activation of integrated transposons Figure 7
Conditional gene-activation of integrated transposons. Colonies from the transfection of pTC-loxPTK-G with pKUb-
SB11 (Fig 5C) were expanded in selective media containing puromycin. DNA from these transgenic colonies was isolated and 
analyzed by Southern hybridization. A) A schematic of pKT2C-loxPTK-G that shows the AseI restriction sites and the location 
of the PTK hybridization probe (diagonal lined rectangle) used for Southern analysis. B) A Southern blot of pKT2C-loxPTK-G 
colonies. The clones were analyzed without Cre excision, so integrants that result from transposition should be equal to or 
greater than the transposon size of 4.9 kb (open arrow). Whereas, bands associated with concatemer formation are found at 
6.0 kb (vertical line arrow). The positions of the DNA marker bands of the 1 kb Quanti-Marker from ISC Bioexpress (Kay-
sville, Utah), are indicated by black dots on the right of each blot with sizes of 12, 10, 8, 6, 5, 4, 3, 2.5, and 2 kb shown. C) 
pKT2C-loxPTK-G colonies were transfected with pPGK-nlsCre and plated under gancyclovir selection. Clones with PTK elim-
inated by recombination became gancyclovir resistant and were counted. Cre-activation of all clones was determined to be sig-
nificant (p < 0.5).BMC Biotechnology 2007, 7:42 http://www.biomedcentral.com/1472-6750/7/42
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tems for transgenesis of porcine cells prior to their use for
the creation of pigs by SCNT to enable increased effi-
ciency, better precision, reliable expression, and selection
cassette recycling. In addition, SB and PB dramatically
improved the transgenesis rate in mice by PNI [32,69],
providing a clear rationale for improving the efficiency of
transgenic pig production via this method.
Recombinases in swine genetics- selection-cassette 
recycling and conditional alleles
There are several immediate applications for recombi-
nases in swine genetics. First, as shown in Fig 5, 6, 7,
recombinases can be combined with a positive/negative
selectable marker like PTK for selection cassette recycling
[52]. Currently, most, if not all transgenic animals pro-
duced by SCNT contain a selectable marker (e.g. neoR,
puroR, GFP) in addition to an experimental transgene.
This selectable marker is useful for the proper identifica-
tion of nuclear donor cells, but generally is undesirable in
the transgenic animal. This could be particularly impor-
tant for removal of xenogenic elements after gene knock-
out or manipulation preceding the introgression of
engineered germplasm into agricultural production herds.
The flanking of selectable markers with RRS provides the
opportunity to eliminate them in culture or by breeding
to Cre expressing pigs, leaving behind only a single 34-
basepair RRS footprint.
Recombinases also permit the creation of conditional
alleles for activation or inhibition of gene function in
response to Cre or Flp recombinase activity, as illustrated
in Figures 6, 7[51]. In addition, the effectiveness of
homologous recombination constructs can be improved
to allow selection cassette recycling, thereby avoiding
'selection cassette interference', whereby the exogenous
regulatory elements in the selection cassette can interfere
with the expression of genes in the vicinity of the targeted
mutation [52]. As has been elegantly demonstrated in
mice, recombinases can also be used to create conditional
knock-outs in pigs when tissue specific ablation is desired,
or when traditional knockout results in embryonic
lethality. The availability of an assortment of transposon
and recombinase systems should also permit serial cellu-
lar transgenesis and recombination to achieve complex
genomic rearrangements in the pig. Serial transgenesis
provides a direct method for the production of pigs that
express several gene products. Given the dramatic long-
range conservation of synteny between pig and human
genomes, far more extensive than for mouse and human,
engineered chromosomal rearrangements between seri-
ally provided RRS in the pig could provide superior large
animal models of human congenital and cancer related
chromosomal abnormalities [53].
Conclusion
Pork represents the single most economically important
meat product in the world and pigs are playing an increas-
ingly critical role in biomedicine. An armamentarium of
effective genetic tools will be required to capture the value
and potential of this species for human nutrition and
health. Here we have tested four transposon and two
recombinase systems for activity in pig cells. SB, PP, Tol2,
and PB and transposons are capable of precise transposi-
tional transgenesis of porcine cells, increasing efficiency
by 4–28 fold. We have also demonstrated that Cre and Flp
recombinases function efficiently in the nucleus of pig
cells for selection-cassette recycling and conditional regu-
lation of transgene expression. The combination of these
tools will significantly improve the efficiency and sophis-
tication of porcine genetic manipulation for enhancing
pig production and human nutrition, as well as modeling
and treating human disease.
Methods
Vector construction
Sequence information, maps, and material requests for
these constructs can be found on our web site [70].
pT2-Floxp-PTK- To generate a multiple cloning sequence
flanked by FRT  and  loxP  recombinase recognition
sequences (FRT-loxP  MCS), two oligonucleotides with
overlapping sequence (shown in bold) were designed,
FRT-loxP  Upper
[ATACCGGCCGGAAGTTCCTATTCCGAAGTTCCTATTCT
CTAGAAAGTATAGGAACTTCATAACTTCGTATAATGTAT-
GCTATACGAAGTTATCTCGAGAATTCCCGGGAG-
GCCTACTAGT], and FRT-loxP  Lower
[GTATTCATGAGAAGTTCCTATACTTTCTAGAGAATAGG
AACTTCGGAATAGGAACTTCATAACTTCGTATAGCATA-
CATTATACGAAGTTATCCATGGACTAGTAGGCCTC-
CCGGGAA]. These oligonucleotides were annealed and
elongated by PCR using Pwo polymerase. The 218 base
pair PCR fragment was cloned into pCR4 using the ZERO
Blunt TOPO PCR Cloning Kit (Invitrogen, USA) to create
pCR4 FRT-loxP MCS, and its sequence was verified. FRT-
loxP MCS was subsequently excised with EagI and BspHI
and cloned into pT2/BH [71] cleaved with EagI and NcoI
to produce pT2-FRT-loxP MCS. Finally, a completely filled
XhoI fragment, containing the mouse PGK promoter, the
PTK fusion protein, and bovine growth hormone poly(A)
signal from YTC37, a kind gift from the laboratory of A.
Bradley [54], was cloned into Sma1 cleaved pT2-FRT-loxP
MCS to produce pT2-FloxP-PTK.
pKUb-SB11- A 1.0 kb fragment of the SB11 transposase
from pCMV-SB11 [72], which had been amplified with
CDS-SB11-F1 [CACCATGGGAAAATCAAAAGAAAT-
CAGCC] and CDS-SB11-R1 [GGATCCCAATTTAAAG-
GCAATGCTACCAAATACTAG] primers and subclonedBMC Biotechnology 2007, 7:42 http://www.biomedcentral.com/1472-6750/7/42
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into an intermediate vector adding a 5' BglII site and the
sequence [AGATCTGAT], was cloned into the BamHI site
of pKUb to make pKUb-SB11. pKUb was made by cloning
nucleotides 3561–4771 of the human UbC gene (gen-
bank accession D63791), which contains the UbC pro-
moter, non-coding exon 1, and intron 1, into pK-SV40(A)
between intact BglII and NheI restriction endonuclease
sites. pK-SV40(A) was made by cloning a single copy of
the SV40 poly(A) signal amplified by PCR with oligos
KJC-SV40(A)-F1 [CATTGATGAGTTTGGACAAACCACA]
and KJC-SV40(A)-R1 [ACCACATTTGTAGAGGTTTTACTT-
GCT] into pK-A10 opened with XmnI. pK-A10 was made
by cloning KJC-Adapter 10 [CTGAGATCTTAAGCTAG-
CAGGATCCAGAATTCATTCAG] into pK digested with
PvuII creating a multiple cloning site with PvuII, BglII,
AflII, NheI, BamHI, EcoRI, XmnI, and PvuII recognition
sites. pK was made by joining an 0.8 kb PCR product of
pBluescriptSK- (Stratagene), containing the pUC_ORI
amplified with oligos KJC-pUC_ORI-F1 [CTGTTCCGCT-
TCCTCGCTCACTGACT] and KJC-pUC_ORI-R1 [AAAAG-
GATCTAGGTGAAGATCCTTTTTGAT], to a 0.9 kb PCR
product of pENTR-D-TOPO (Invitrogen), which contains
the kanamycin resistance gene amplified by oligos KJC-
KanR-F1 [CTGCATCATGAACAATAAAACTGTCTGCT]
and KJC-KanR-R1 [TGCCAGTGTTACAACCAATTAAC-
CAAT]. The junction of ORI-F1 to KanR-R1 created a sin-
gle PvuII site.
pCMV-β is available from Clontech (Mountainview, CA).
pPGK(nls)CRE was a kind gift of Dr. David Largaespada's
lab at the University of Minnesota.
pKT2P-(nls)FLP- A Flp open reading frame containing the
large T antigen nuclear localization signal (bold) and a
Kozak consensuses sequence was generated by amplifying
the Flp open reading frame using primers CDS Kozak-NLS
Flp 5' [ATATCTCGAGGCCACCATGGCTCCCAAGAA-
GAAGAGGAAGGTGATGAGTCAATTTGATATATTATG-
TAAAAC] and CDS Flp 3'
[ATATAGATCTTTATATGCGTCTATTTATGTAGG] using
pOG44 (Invitrogen, USA) as template. The resulting PCR
product was cloned into pCR4 using the ZERO Blunt
TOPO PCR Cloning Kit (Invitrogen, USA) creating pCR4-
nlsFlp. The nlsFlp open reading frame was subsequently
excised with XhoI and BglII and inserted into XhoI-BglII
cleaved pKT2-PGKi to produce pKT2P-nlsFlp. pKT2-PGKi
contains the human PGK promoter, a kind gift of Dr. Scott
McIvor (University of Minnesota) in front of the mini-
intron, MCS, and rabbit beta-globin 3'UTR found in mini-
CAGs.
pKT2C-EGFP was made by cloning a 0.7 kb XhoI to BglII
fragment of pKT2P-GeN into pKT2-mCAG opened from
BglII to XhoI. pKT2-mCAG was made by cloning a 2.2 kb
BamHI to KpnI fragment of pSBT-mCAG [73] into pK-A3
opened from BamHI to KpnI. pKT2P-GeN was made by
cloning EGFP as a 0.75 kb EcoRI fragment from pCR4-
EGFP into the EcoRI site of pKT2P-eNeo. pCR4-EGFP was
made by cloning a PCR fragment of EGFP from pEGFP-N1
(Clontech) amplified with primers KJC-EGFP-F3
[CCGAATTCTACCATGGTGAGCAAGGGCGAG] and KJC-
EGFP-R2 [CCAGATCTTTACTTGTACAGCTCGTCCATGC]
into pCR4-TOPO (Invitrogen). pKT2P-eNeo contains the
encephalomyocarditis virus internal ribosome entry site
and neomycin resistance gene amplified from pGT-Neo
[62] with KJC-BactinSA-F1 [CACTGAAGTGTTGACTTC-
CCTGACAGC] and KJC-Bgeo-R1 [TTCAATTGTTAGAA-
GAACTCGTCAAGAAGGCGA]. The eNeo cassette was
subcloned and acquired a modified sequence at the 3' end
[GTTAACTT] to [GTTAAGTCTAGA] including a BglII site.
The 1.4 kb eNeo cassette was isolated with EcoRI and BglII
and moved into pKT2-PGKi opened from BglII to EcoRI.
pKT2P-PTK was made by cloning a 2.7 kb PvuII fragment
from pKP-PTK_TS into pKT2-RV opened with EcoRV.
pKT2-RV was made by cloning a 0.6 kb BamHI to KpnI
fragment of pSBT-RV [73] into pK-A3 opened with BamHI
and KpnI. pK-A3 was made by opening pK with PvuII and
inserting KJC-Adapter 3 [CTGGATCCAGATCTGGTAC-
CATTTAAAT] creating a small multiple cloning site with
PvuII, BamHI, BglII, KpnI, and SwaI sites. pKP-PTK_TS
was made by cloning a 2.3 kb BglII to EcoRI fragment of
pCR4-PGK-PTK into the MCS of pK-SV40(×2) opened
with EcoRI and BglII. pCR4-PGK-PTK was made by clon-
ing a 2.3 kb PCR product of pT2-FloxP-PTK amplified
with PuroΔTK-F1 [TTAGATCTGGCCTCGCACACATTC-
CACAT] and PuroΔTK-R1 [TGGTTCTTTCCGCCTCA-
GAAGCCAT] into pCR4-TOPO (Invitrogen). pK-
SV40(×2) was made by cloning two copies of the SV40
poly(A) signal amplified by PCR with oligos KJC-
SV40(A)-F1 [CATTGATGAGTTTGGACAAACCACA] and
KJC-SV40(A)-R1 [ACCACATTTGTAGAGGTTTTACTT-
GCT] into pK-A10 opened with XmnI.
pTol2-PTK- The mini Tol2 transposon donor plasmid was
constructed by inserting the PvuII fragment of pKP-PTK-
TS into pGemT-Tol2 [74,75] opened from SwaI to HindIII
(filled) to produce pGTol2P_PTK.
pCMV-Tol2 was constructed as indicated [74] from previ-
ously described materials [75].
pPBTP-PTK was made by cloning a 2.7 kb PvuII fragment
of pKP-PTK_TS into pPBT-SE opened from SmaI to EcoRV.
pPBT-SE was made by cloning the 102 bp PCR product
containing an outward facing T7 polymerase site, the SE
multiple cloning site, and an outward facing T3 polymer-
ase site into pPBT cut with MscI. The PCR product was
amplified from pKT2-SE using T7-RevComp [TCTC-BMC Biotechnology 2007, 7:42 http://www.biomedcentral.com/1472-6750/7/42
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CCTATAGTGAGTCGTATTA] and T3-RevComp [TCTC-
CCTTTAGTGAGGGTTAATT] primers. pPBT was made by
cloning the PB LTR1 and LTR2 into pKT2-SE from KpnI to
BamHI. LTR1 and LTR 2 from PB were amplified from
pXL-Bac-II, a kind gift of Malcolm Fraser (Notre Dame
University), using PB-LTR1-F1 [TGGATCCCAATCCT-
TAACCCTAGAAAGATAATCATATTG] and PB-LTR1-R1
[GTGGCCATAAAAGTTTTGTTACTTTATAGAAG] or PB-
LTR2-F1 [TTGGCCATAAGTTATCACGTAAGTAGAA-
CATG] and PB-LTR2-R1 [TGGTACCTAGATTAACCCTA-
GAAAGATAGTCTG], respectively. LTR1 and LTR2 PCR
products were cloned into pCR4 vector (Invitrogen) and
subsequently excised by BamHI and MscI or MscI and
KpnI digestion, respectively. pKT2-SE was made by clon-
ing the 0.7 kb BamHI to KpnI fragment containing the SB
inverted repeats and SE multiple cloning site from pSBT-
SE [73] into pK-A3 opened from KpnI to BamHI.
pKC-PB was made by inserting the 2.1 kb NheI to BamHI
fragment of p3XP3-DsRed, a kind gift of Dr. Malcolm Fra-
ser (Notre Dame University), containing the PB trans-
posase coding sequence into the 3.2 kb BamHI to NheI
fragment of pKC-SB11, which resulted in the exchange of
SB11 with PB transposase.
pPTnP-PTK- A 2.7 kb PvuII to PvuII fragment of pKP-
PTK_TS was cloned into the EcoRV site of pPTn2-RV to
make pPTnP-PTK. pPTn2-RV was made by cloning KJC-
Adapter 4 [TCTCCCTTTAGTGAGGGTTAATTGA-
TATCTAATACGACTCACTATAGGGAGA] into the MscI
site of prePTn2(-1) creating T7 and T3 polymerase bind-
ing sites orientated out towards the inverted repeats of the
PTn transposon and separated by an EcoRV site.
prePPTn2(-1) was made by cloning a 0.5 kb BamHI to
KpnI fragment of pCR4-PPTN2A into pK-A3 opened from
KpnI to BamHI. pCR4-PPTN2A was created by topo clon-
ing a 0.5 kb PCR product amplified from prePPTN2(-2)
using oligos PPTN-F1 (BamHI) [AAGGATCCGATTA-
CAGTGCCTTGCATAAGTAT] and PPTN-R1 (KpnI) [AAG-
GTACCGATTACAGTGCCTTGCATAAGTATTC] into
pCR4-Topo (Invitrogen). prePPTN2(-2) was created by
amplifying the majority of pBluKS-PPTN5 [29], a kind gift
of Dr. Michael Leaver (University of Stirling, UK), with
oligos PPTN-OL2 [CCATCTTTGTTAGGGGTT-
TCACAGTA] and PPTN-OR1 [CCAGGTTCTACCAAG-
TATTGACACA]. The PCR fragment was then self-ligated to
produce an empty transposon with a single MscI site in its
interior.
pKC-PTs1 was made by cloning a 1.0 kb NheI to EcoRI
fragment of pKUb-PTs1 that contained the PPTN trans-
posase (PTs) into pK-mCAG opened from EcoRI to NheI.
pK-mCAG was made by cloning the mCAG promoter
from pSBT-mCAG [73] as a 0.96 kb SmaI to EcoRI (filled)
fragment into pK-SV40(A) × 2 opened with AflII (filled).
pKUb-PTs1 was made by replacing the SB11 gene from
pKUb-SB11 with PTs by cloning a 1.0 kb BamHI to NheI
fragment from pCR4-PPTs1B into pKUb-SB11 from NheI
to BamHI. pCR4-PPTs1B was made by cloning a PCR frag-
ment of pBluKS-PPTN4 [29], a kind gift of Dr. Michael
Leaver (University of Stirling, UK), amplified with primers
CDS-PPTs-F1 [AAAGCTAGCATGAAGACCAAGGAGCT-
CACC] and CDS-PPTs-R1 [AAGGATCCTCAATACTTGG-
TAGAACC] into pCR4-Topo (Invitrogen).
pKT2C-loxPTK-G was made by cloning a 2.3 kb PvuII frag-
ment of pK-PTK_TS into the MscI site of pKT2C-lox-GFP.
pK-PTK_TS was made by cloning a 1.9 kb BglII to EcoRI
fragment of pCR4-PTK into the MCS of pK-SV40(×2)
opened with EcoRI and BglII. pCR4-PTK was made by
cloning a 1.9 kb PCR product of pT2-FloxP-PTK using oli-
gos PuroΔTK-F2 [TTAGATCTACCATGACCGAGTA-
CAAGCCCA] and PuroΔTK-R1
[TGGTTCTTTCCGCCTCAGAAGCCAT] into pCR4-TOPO
(Invitrogen). pKT2C-lox-GFP was made by cloning 0.1 kb
EcoRI fragment of pCR4-loxP, which contains two direct
repeat loxP sites separated with a MscI site, into pKT2C-
EGFP opened with EcoRI. pCR4-loxP was made by topo
cloning the annealed and extended oligos loxP-F1
[ATAACTTCGTATAATGTATGCTATACGAAGTTATCTC-
GAGTGGCCA] and loxP-R1 [ATAACTTCGTATAGCATA-
CATTATACGAAGTTATTGGCCACTCGAG] into pCR4-
TOPO (Invitrogen).
Cell Culture and transposition/recombinase assays
Pig fibroblasts were isolated from 43 day old embryos.
The tissue was dissociated using a collagenase/DNAse I
treatment as well as mechanical disruption. The cells from
the female piglet #8 were cultured in DMEM enriched
with 10%FBS and 2× antibiotic/antimycotic solution
(Gibco #15240-022). The cells were passaged in DMEM
high glucose media enriched with 10% FBS, 2 mm L-
glutamine, 1× P/S until spontaneously establishing line
PF8. A subpopulation of porcine endometrial gland epi-
thelium cells [76] were spontaneously immortalized,
strain PEGE. The PEGE cells were maintained in DMEM
supplemented with 10% FCS, 1× Penn/Strep, 10 μg/ml
Insulin (Sigma, USA), and 1× L-Glutamine.
For transposition assays cells were plated in each well of a
six well plate to achieve 60–80% confluence within 6–24
hours. Cells were transfected using TransIT-LT1 (Mirus Bio
Corporation, WI) transfection reagent according to the
manufactures instructions with a ratio of 3:1 lipid: μg
DNA. Each transfection contained a total of 1.15 to 1.5 μg
of plasmid DNA. Wells 1–3 contained transposon plus
transposase, well 4 contained transposon with no trans-
posase, well 5 contained SB plus SB transposase and well
6 contained pKT2C-EGFP only. Molar amounts of each
transposon were fixed at 1.5 × 10-13 moles of transposonBMC Biotechnology 2007, 7:42 http://www.biomedcentral.com/1472-6750/7/42
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(0.75 × 10-13 Moles for Tol2) while transposase plasmid
was added at a molar ratio of 1:1 for SB, Tol2, and PB, and
1:0.5 for PP. The choice of the promoters and transfection
ratios for SB and PP was based on the highest transposi-
tion activity observed in human HT1080 cells (data not
shown). Strong promoters (CMV & miniCAGs) and trans-
fection conditions for Tol2 and PB were selected based on
previously published data and the observation that these
transposon systems seem less susceptible to overexpres-
sion inhibition than SB and PP.[34,61,74] Total DNA
weight was adjusted using pCMV-β plasmid. Forty-eight
hours after transfection cells were trypsinized, and two
replicates of 60,000 cells were plated onto 100 mm plates
in media containing 0.3 μg/ml puromycin and selected
for 9–12 days. Colonies were visualized by methylene
blue staining and counted. A minimum of two six-well
plates were transfected for each experiment. The mean col-
ony number and standard error are shown in figures.
Southern hybridizations
Several independent puromycin resistant PEGE foci for
each transposon were aspirated and grown to confluence
on a 100 mm plate. Genomic DNA was extracted using
standard methods and approximately 10 μg was digested
with SspI (Tol2 clones) or AseI (SB, PB, and PP) clones.
Digested DNA was separated on 0.7% agarose gel and
transferred to positively charged nylon membranes (GE
Osmotics, USA). Membranes were probed with a random
primed 1524 bp XmaI fragment of pKP-PTK-TS that con-
tained the bulk of the PTK gene and visualized by autora-
diography or phosphor imaging.
Cloning transposon junctions
Genomic DNA was isolated from pooled, fixed, and
stained puromycin resistant clones for each transposon.
For splinkerette PCR DNA was cut with Sau3AI or NlaIII
and junctions were cloned as described [69]. For blocked
linker-mediated PCR, DNA was cut with NspI for Tol2 and
SB, and a cocktail of enzymes including XbaI, AvrII, NheI
and SpeI for PB and PP. The NspI digested DNA was
ligated to the blocked linker-SphI that was created by
annealing primerette-long [CCTCCACTACGACTCACT-
GAAGGGCAAGCAGTCCTAACAACCATG] and blink-
SphI [5'P- GTTGTTAGGACTGCTTGC-3'P]. Whereas the
DNA digested with the cocktail was ligated to the blocked
linker-XbaI that was produced by annealing primerette
long to blink-XbaI [5'P-CTAGCATGGTTGTTAGGACT-
GCTTGC-3'P]. Following ligation the junction sequences
were amplified by nested PCR. The primary PCR used the
common primer primerette-short [CCTCCACTACGACT-
CACTGAAGGGC] with transposon-specific primers
SB_IRDR(L)-O1 [ATTTTCCAAGCTGTTTAAAG-
GCACAGTCAAC], Tol2(L)-O1 [AATTAAACTGGGCAT-
CAGCGCAATT], PB-LTR(R)-O1
[ACAGACCGATAAAACACATGCGTCAA], and PTn-
IRDR(R)-O1 [GGGTGAATACTTATGCACCCAACA-
GATG]. The secondary PCR reactions used the common
primer primerette-nested [GGGCAAGCAGTC-
CTAACAACCATG] with transposon-specific primers
SB_IRDR(L)-O2 [GACTTGTGTCATGCACAAAGTAGAT-
GTCCT], Tol2(L)-O2 [GCGCAATTCAATTGGTTTGG-
TAATAGC], PB-LTR(R)-O2
[TCCTAAATGCACAGCGACGGATTC], and PTn-IRDR(R)-
O2 [CAGTACATAATGGGAAAAAGTCCAAGGG]. To gen-
erate unique sequences serial dilutions (1:50 and 1:500)
of the ligation reaction were used as template for the pri-
mary PCR. The primary PCR was diluted 1:50 and used as
template in the secondary PCR reaction. The PCR frag-
ments were shotgun cloned and sequenced.
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